Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON48687
NL-OMON48687
Recruiting
Not Applicable

*The PreRisk calculator in suspected or confirmed preeclampsia: A new tool to safely reduce the number of unnecessary admissions* - The PreRisk study

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites864 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
864
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Women (\>\=18 years) with (suspected) PE with a singleton pregnancy and a
  • •gestational age of \>\= 20 weeks and \<37 weeks.
  • •PE defined as de novo onset hypertension (systolic blood pressure of \>\=140 and
  • •diastolic blood pressure of \>\=90mm Hg) and proteinuria (protein\-to\-creatinine
  • •ratio \>\=30mg/mmol or \>\= 300mg/24h, or 2\+ dipstick) at or after 20 weeks of

Exclusion Criteria

  • •Multiple pregnancies
  • •Not willing to give written informed consent.
  • •Other reasons than (suspected) PE requiring hospitalization
  • •The presence of HELLP syndrome at time of inclusion
  • •Fetal death at time of inclusion.
  • •Pregnancy with a fetus affected by major congenital birth defects and/or
  • •chromosomal abnormalities

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
The PreRisk calculator in suspected or confirmed preeclampsia: A new tool to safely reduce the number of unnecessary admissions’
NL-OMON22891one864
Not yet recruiting
Not Applicable
A risk-predictive score for developing Non-Alcoholic Fatty Liver Disease (NAFLD) using biochemical markersHealth Condition 1: K758- Other specified inflammatory liverdiseases
CTRI/2022/12/048328PG Grants, Kasturba Medical College
Completed
Not Applicable
Investigation of prediction abilities for a risk of hypoglycemia of intermediate-term glycemic variability metrics using continuous glucose monitor datatype 2 diabetes
JPRN-UMIN000032899Inuyama Chuo General Hospital104
Completed
Not Applicable
Practical risk stratification score for prediction of contrast&#45;induced nephropathy after primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction: development and internal validatioContrast&#45induced nephropathy was defined as the deterioration of renal function following the administration of contrast agents and unlikely to be explained by other possible causes. Patients with anprediction score&#44contrast&#45induced nephropathy&#44STEMI
TCTR20190705001/A217
Recruiting
Not Applicable
Quality assessment of report in clinical biochemistry laboratory using Sigma scale.
CTRI/2017/02/007756Father Muller Medical College institutional grants committee100